Indivior PLC, a high-risk pharmaceutical company based in the United States, specializes in the production of specialty and generic drugs. With a focus on ESG principles, Indivior PLC develops, manufactures, and sells prescription medications for substance use disorders and severe mental illnesses. Key products include Sublocade, Perseris, and Suboxone. The company's revenue primarily comes from the United States, with additional earnings from the United Kingdom and international markets.